Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Varicella Zoster Virus Infection 1Herpes Simplex 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1

Interventions

ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Valganciclovir 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Matrix-M 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1Gene-Eden-VIR 1Fosfomycin 1Clozapine 1Ciprofloxacin 1Cidofovir 1Cefepime 1Bosentan 1Aminocaproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Herpes Simplex × Gene-Eden-VIR × Clear all
NCT02715752 2016-04-26

A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

The Center for the Biology of Chronic Disease

Completed
1,000 enrolled

Varicella Zoster Virus Infection, Cytomegalovirus Infections, Herpes Simplex, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡